Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response
ConclusionThese results suggest that fargesin inhibits atherosclerosis by promoting RCT process and reducing inflammatory response via CEBPαS21/LXRα and TLR4/NF-κB pathways, respectively.
Source: Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids - Category: Lipidology Source Type: research
More News: Biology | Cholesterol | Cytology | Diets | Genetics | High Fat | Lipidology | Molecular Biology | Nutrition